title: Surgery in the treatment of multidrug-resistant tuberculosis.
abstract: Resectional surgery is recommended for patients with localized multidrug-resistant tuberculosis if adequate pulmonary reserve is present. Appropriate drug specific therapy is employed for approximately 3 months preoperatively and for 18 to 24 months postoperatively. Nutrition is emphasized both pre- and postoperatively. Technically, the use of bronchoscopy, double lumen endotracheal tubes, and muscle or omental flaps is stressed. With the above, cure rates should be better than 90%.
authors.affiliation: Division of Cardiothoracic Surgery, University of Colorado Health Sciences Center, Denver, USA.
authors.forename: M
authors.initials: M
authors.lastname: Pomerantz
authors.forename: J M
authors.initials: JM
authors.lastname: Brown
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage; D001999:Bronchoscopy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D009747:Nutritional Physiological Phenomena; D013524:Surgical Flaps; D014057:Tomography, X-Ray Computed; D018088:Tuberculosis, Multidrug-Resistant / Q000000981:diagnostic imaging / Q000601:surgery*; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000601:surgery*
chemical_list: D000995:Antitubercular Agents